Rheumatoid Arthritis Clinical Trials in Houston

Showing 2081-2100 of 3,412 trials

Safety and Efficacy of SPD465 in Adults With ADHD

NCT00202605

The purpose of the study is to evaluate how safe and how well SPD465 works compared to placebo in adults with ADHD. It is hypothesized that SPD465 will achieve an extended duration of clinical benefit.

Attention Deficit Disorder With Hyperactivity

Shire72 participantsStarted Sep 2005

Little Rock, Arkansas, United States • Irvine, California, United States • Las Vegas, Nevada, United States +1 more locations

COMPLETEDPhase 2< 1 mile

Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer

NCT03377556

This phase II trial studies how well talazoparib works in treating patients with homologous recombination repair deficiency (HRRD) positive stage IV squamous cell lung cancer that has come back after previous treatment. Talazoparib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

ATM Gene MutationATR Gene MutationBARD1 Gene Mutation+18 more

SWOG Cancer Research Network51 participantsStarted Mar 2017

Birmingham, Alabama, United States • Anchorage, Alaska, United States • Anchorage, Alaska, United States +1154 more locations

Safety and Efficacy of SPD465 in Adults With ADHD

Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer

Rheumatoid Arthritis Trials in Other Cities

Strategies in Maintenance for Patients Receiving Long-term Therapy (S.I.M.P.L.E.) With MMX (Multi-Matrix System) Mesalamine for Ulcerative Colitis (UC)

Lisdexamfetamine Dimesylate (LDX) Pilot Cognition Study to Evaluate the Utility of a Standardized Battery of Tests in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)

Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and Placebo

Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate

A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis

SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)

Ability to Maintain or Achieve Clinical and Endoscopic Remission With MMX Mesalamine Once Daily in Adults With Ulcerative Colitis

Safety, Tolerability, Pharmacokinetic, and Efficacy Study of SPD489 in Preschool Children With Attention-deficit/Hyperactivity Disorder

Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder

Phase 3 Study of Dexpramipexole in ALS

Safety and Tolerability Study of SHP465 in Children Aged 4 to 12 Years Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD)

Safety and Efficacy of NPS 1776 in the Acute Treatment of Migraine Headaches

Seven vs. 14 Days Treatment for Male Urinary Tract Infection

CD19-Specific T Cells Post AlloSCT

Filgotinib Alone and in Combination With Methotrexate (MTX) in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Are Naive to MTX Therapy

Study of Safety and Efficacy of a rhPTH[1-84] of Fixed Doses of 25 and 50 mcg in Adults With Hypoparathyroidism (RELAY)

Regimen Optimization Study

(C2013-0302) Safety and Efficacy of Escalating Doses of SAN-300 in Patients With Rheumatoid Arthritis

Other Conditions in Houston